Which research institution led the first in-utero treatment for Spinal Muscular Atrophy (SMA)?
St. Jude Children’s Research Hospital
Why is the news?
“Scientists Achieve First In-Utero Treatment for Spinal Muscular Atrophy Using Risdiplam”
St. Jude Children’s Research Hospital led the first in-utero treatment for Spinal Muscular Atrophy (SMA) using the oral drug risdiplam. This breakthrough offers hope for early intervention in SMA, a neurodegenerative disorder that begins affecting individuals before birth.
Similar Questions
Who led the team that explored innovative approaches to combat Alzheimer’s disease at the Bose Institute?
AMRSense, an AI-driven tool for tracking antimicrobial resistance (AMR), primarily aims to:
Which research institution led the first in-utero treatment for Spinal Muscular Atrophy (SMA)?
Important Questions from Health
Who led the team that explored innovative approaches to combat Alzheimer’s disease at the Bose Institute?
Which parasitic disease has Niger officially eliminated as a public health threat?
Which country has initiated the first-ever clinical trial for a vaccine targeting the Sudan species of the Ebola virus?
Consider the following statements:
Statement-I- Biolumpivaxin vaccine is expected to provide long-lasting immunity against all strains of the Lumpy Skin Disease virus.
Statement-II- Vaccines typically stimulate the immune system to produce antibodies that can neutralize the specific pathogen they are designed to target
Which one of the following is correct in respect to the above statements?
Consider the following statements:
Statement-I- Biolumpivaxin vaccine is expected to provide long-lasting immunity against all strains of the Lumpy Skin Disease virus.
Statement-II- Vaccines typically stimulate the immune system to produce antibodies that can neutralize the specific pathogen they are designed to target
Which one of the following is correct in respect to the above statements?
